{
  "report_rows": [
    {
      "kpi": "Organic Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+2.5% vs. cons +1.98% (VA, Jul 27)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating Margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~27.1% vs. cons 26.90% (VA, Jul 27)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.87 vs. cons $2.807 (VA, Jul 27)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Operating EPS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$11.55 mid vs. cons $11.32 (VA, Jul 27)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Organic Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~2-3% (mid 2.5%) vs. cons 2.06% (VA, Jul 27)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Operating Margin (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide maintained 26.5-27.5% vs. cons 26.88% (VA, Jul 27)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 organic beat forces H2 estimate revisions upward; sell-side raises Q3/Q4 over the following week",
  "day5_confidence": "MEDIUM"
}